Q&A: Can you use medicine and prescriptions past the expiration date?
When a headache calls and the only ibuprofen in the house is a bottle that is expired, is it worth a trip out to replace it?
Oct 24, 2023
0
3
When a headache calls and the only ibuprofen in the house is a bottle that is expired, is it worth a trip out to replace it?
Oct 24, 2023
0
3
Past public ire over high drug prices has recently taken a back seat to a more insidious problem—no drugs at any price.
Jul 20, 2023
0
0
President Joe Biden signed an executive order Sept. 12 to launch a National Biotechnology and Biomanufacturing Initiative, noting the United States relies too heavily on foreign materials and foreign bioproduction. Offshoring ...
Oct 3, 2022
0
4
When drug manufacturers raise the list price for brand-name prescription drugs, do patients' out-of-pocket costs rise too? A new study published in JAMA Network Open by Dr. Benjamin Rome and colleagues in the Brigham's Division ...
May 4, 2021
0
0
Given the AstraZeneca COVID-19 vaccine is no longer recommended for under-50s following news of very rare blood clots, Australia is looking to other vaccines to plug the gap.
Apr 28, 2021
0
1
In an industrial neighborhood on the outskirts of Bangladesh's largest city lies a factory with gleaming new equipment imported from Germany, its immaculate hallways lined with hermetically sealed rooms. It is operating at ...
Mar 1, 2021
0
9
A new assessment of the Medicare Part D program based on a proposal from the West Health Policy Center finds that Medicare beneficiaries would save $29 billion if drug manufacturer rebates were used to reduce their out-of-pocket ...
Dec 19, 2019
0
1
A new analysis of publicly reported financial data published today by researchers at West Health Policy Center and Johns Hopkins Bloomberg School of Public Health finds that large, brand-name drug manufacturers would still ...
Nov 14, 2019
1
1
Demand for prescription medications in the U.S. is at an all time high, given that 50% of adults have at least one chronic condition, and 25% have two or more. Sixty percent of the population, and 90% of Medicare beneficiaries ...
Sep 11, 2019
0
2
The system that allows patients rapid access to expensive new treatments lacks transparency and penalises small and low-income countries unable to negotiate lower prices with pharmaceutical manufacturers. Writing in the Journal ...
Dec 8, 2014
0
0